Hyaluronidase
API-H001-CLN-A2
Phase 2 small_molecule completed
Quick answer
Hyaluronidase for Allergic Skin Reaction is a Phase 2 program (small_molecule) at Amphastar Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Amphastar Pharmaceuticals
- Indication
- Allergic Skin Reaction
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed